B4GALT1 Gene - Beta-1,4-Galactosyltransferase 1

Key enzyme in glycoprotein and glycolipid biosynthesis, involved in congenital disorders of glycosylation and cancer.

Gene Information Card

Symbol B4GALT1
Full Name Beta-1,4-Galactosyltransferase 1
Gene Type Protein coding
Chromosomal Location 9p21.1
NCBI Gene ID 2683 ncbi.nlm.nih.gov/gene/2683
Ensembl ID ENSG00000086062
UniProt ID P15291
OMIM ID 137060
HGNC ID 924
Aliases B4GAL-T1, GGTB2, GT1, GTB, beta4Gal-T1

Description

B4GALT1 encodes beta-1,4-galactosyltransferase 1, a type II membrane-bound glycoprotein that catalyzes the transfer of galactose from UDP-galactose to N-acetylglucosamine (GlcNAc) residues on glycoproteins and glycolipids. It is a key enzyme in the biosynthesis of N-linked and O-linked glycans, and also forms part of the lactose synthase complex. Mutations in B4GALT1 cause congenital disorder of glycosylation type IId (CDG IId). Altered expression is associated with various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Congenital disorder of glycosylation type IId (CDG IId) Loss-of-function mutations in B4GALT1 impair N-glycan galactosylation, leading to multisystem developmental abnormalities. OMIM #607091; ClinVar
Colorectal cancer Overexpression of B4GALT1 enhances cell surface galactosylation, promoting tumor cell adhesion and metastasis. PubMed; COSMIC
Hepatocellular carcinoma Upregulation of B4GALT1 correlates with poor prognosis and increased metastatic potential. PubMed; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 32.5 High
Kidney 18.2 Medium
Small intestine 15.8 Medium
Pancreas 12.1 Medium
Lung 8.4 Low
Brain 5.3 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 (liver) 45.2 High expression
HeLa (cervical) 22.1 Moderate expression
A549 (lung) 9.7 Low expression
MCF7 (breast) 14.5 Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.103C>T (p.Arg35Cys) Missense Rare Loss of galactosyltransferase activity; associated with CDG IId
c.680G>A (p.Arg227His) Missense Rare Reduced enzyme activity; reported in CDG IId
c.1A>G (p.Met1Val) Start loss Very rare Complete loss of protein; severe CDG phenotype
Mutation functional classification

Loss of Function (LOF)

Missense and start-loss mutations reduce or abolish galactosyltransferase activity, leading to CDG IId.

Gain of Function (GOF)

Not reported in B4GALT1.

Dominant Negative (DN)

Not reported in B4GALT1.

Pathways

N-glycan biosynthesis (Reactome R-HSA-446203)
Lactose synthesis (Reactome R-HSA-5653892)
Glycosphingolipid biosynthesis (KEGG hsa00601)

Protein Summary

Beta-1,4-galactosyltransferase 1 is a 398-amino acid type II transmembrane protein localized to the Golgi apparatus. It catalyzes the transfer of galactose to terminal GlcNAc residues on glycoproteins and glycolipids, forming the Galβ1-4GlcNAc linkage. The protein has a short N-terminal cytoplasmic tail, a transmembrane domain, and a large luminal catalytic domain. It also associates with alpha-lactalbumin to form lactose synthase, enabling lactose production in the mammary gland.

Related Products

Product name Cat.No. Species Gene ID
B4GALT1 Knockout HEK293 Cell Line EDJ-KQ4707 Human 2683 Details Get a Quote
B4GALT1 Knockout A-549 Cell Line EDJ-KQ27426 Human 2683 Details Get a Quote
B4GALT1 Knockout HCT 116 Cell Line EDJ-KQ27427 Human 2683 Details Get a Quote
B4GALT1 Knockout HeLa Cell Line EDJ-KQ27428 Human 2683 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: